Efficacy of Botulinum Type A Injection for the Treatment of Postherpetic Neuralgia and Pruritus Persisting for More Than Four Years—A Case Report
Abstract
1. Introduction
2. Case Presentation
3. Discussion
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Gónima Valero, E.; Mendoza, W.A.S.; Sarmiento, D.A.; Amaya, S. Analgesic treatment approach for postherpetic neuralgia: A narrative review. J. Pain Palliat. Care Pharmacother. 2023, 37, 184–193. [Google Scholar] [CrossRef] [PubMed]
- Dworkin, R.H.; White, R.; O’Connor, A.B.; Baser, O.; Hawkins, K. Healthcare costs of acute and chronic pain associated with a diagnosis of herpes zoster. J. Am. Geriatr. Soc. 2007, 55, 1168–1175. [Google Scholar] [CrossRef] [PubMed]
- Lydick, E.; Epstein, R.S.; Himmelberger, D.; White, C.J. Herpes zoster and quality of life: A self-limited disease with severe impact. Neurology 1995, 45 (Suppl. S8), S52–S53. [Google Scholar] [CrossRef] [PubMed]
- Park, C.; John, H.; Lee, J.; Hong, S.; Kim, M.; Park, S.; Kim, J.H. The relative frequency of pruritus in postherpetic neuralgia patients presenting to the pain clinic and associative factors. Medicine 2022, 101, e30208. [Google Scholar] [CrossRef] [PubMed]
- Hassan, S.; Cohen, P.R. Postherpetic pruritus: A potential complication of herpes zoster virus infection. Cureus 2019, 11, e5665. [Google Scholar] [CrossRef]
- Van Wijck, A.J.M.; Wallace, M.; Mekhail, N.; van Kleef, M. Evidence-based interventional pain medicine according to clinical diagnoses. 17. Herpes zoster and post-herpetic neuralgia. Pain Pract. 2011, 11, 88–97. [Google Scholar] [CrossRef] [PubMed]
- Jeon, Y.H. Herpes zoster and postherpetic neuralgia: Practical consideration for prevention and treatment. Korean J. Pain 2015, 28, 177–184. [Google Scholar] [CrossRef] [PubMed]
- Dworkin, R.H.; Gnann, J.W., Jr.; Oaklander, A.L.; Raja, S.N.; Schmader, K.E.; Whitley, R.J. Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia. J. Pain 2008, 9 (Suppl. S1), S37–S44. [Google Scholar] [CrossRef]
- Apalla, Z.; Sotiriou, E.; Lallas, A.; Lazaridou, E.; Ioannides, D. Botulinum toxin A in postherpetic neuralgia: A parallel, randomized, double-blind, single-dose, placebo-controlled trial. Clin. J. Pain 2013, 29, 857–864. [Google Scholar] [CrossRef]
- Hu, Y.; Zou, L.; Qi, X.; Lu, Y.; Zhou, X.; Mao, Z.; Chen, X.; Liu, K.; Yang, Y.; Wu, Z.; et al. Subcutaneous botulinum toxin-A injection for treating postherpetic neuralgia. Dermatol. Ther. 2020, 33, e13181. [Google Scholar] [CrossRef]
- Xiao, L.; Mackey, S.; Hui, H.; Xong, D.; Zhang, Q.; Zhang, D. Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia. Pain Med. 2010, 11, 1827–1833. [Google Scholar] [CrossRef] [PubMed]
- Moon, Y.E.; Choi, J.H.; Park, H.J.; Park, J.H.; Kim, J.H. Ultrasound-guided nerve block with botulinum toxin type A for intractable neuropathic pain. Toxins 2016, 8, 18. [Google Scholar] [CrossRef] [PubMed]
- Baron, R.; Binder, A.; Wasner, G. Neuropathic pain: Diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010, 9, 807–819. [Google Scholar] [CrossRef] [PubMed]
- Forbes, H.J.; Thomas, S.L.; Smeeth, L.; Clayton, T.; Farmer, R.; Bhaskaran, K.; Langan, S.M. A systematic review and meta-analysis of risk factors for postherpetic neuralgia. Pain 2016, 157, 30–54. [Google Scholar] [CrossRef] [PubMed]
- Park, J.; Park, H.J. Botulinum toxin for the treatment of neuropathic pain. Toxins 2017, 9, 260. [Google Scholar] [CrossRef] [PubMed]
- Gharib, K.; Mostafa, A.; Elsayed, A. Evaluation of botulinum toxin type A injection in the treatment of localized chronic pruritus. J. Clin. Aesthet. Dermatol. 2020, 13, 12–17. [Google Scholar] [PubMed]
- Ri, S.; Kivi, A.; Wissel, J. The safety and effect of local botulinumtoxin A injections for long-term management of chronic pain in post-herpetic neuralgia: Literature review and cases report treated with incobotulinumtoxin A. J. Pers. Med. 2021, 11, 758. [Google Scholar] [CrossRef] [PubMed]
- Naumann, M.; Carruthers, A.; Carruthers, J.; Aurora, S.K.; Zafonte, R.; Abu-Shakra, S.; Boodhoo, T.; Miller-Messana, M.A.; Demos, G.; James, L.; et al. Meta-analysis of neutralizing antibody conversion with onabotulinumtoxinA (BOTOX®) across multiple indications. Mov. Disord. 2010, 25, 2211–2218. [Google Scholar] [CrossRef]
- Yuan, R.Y.; Sheu, J.J.; Yu, J.M.; Chen, W.T.; Tseng, I.J.; Chang, H.H.; Hu, C.J. Botulinum toxin for diabetic neuropathic pain: A randomized double-blind crossover trial. Neurology 2009, 72, 1473–1478. [Google Scholar] [CrossRef]
- Monheit, G. Neurotoxins: Current concepts in cosmetic use on the face and neck: Upper face (glabella, forehead, and crow’s feet). Plast. Reconstr. Surg. 2015, 136, 72S–75S. [Google Scholar] [CrossRef]
- Anido, J.; Arenas, D.; Arruabarrena, C.; Domínguez-Gil, A.; Fajardo, C.; Mira, M.; Murillo, J.; Ribé, N.; Rivera, H.; Ruiz Del Cueto, S.; et al. Tailored botulinum toxin type A injections in aesthetic medicine: Consensus panel recommendations for treating the forehead based on individual facial anatomy and muscle tone. Clin. Cosmet. Investig. Dermatol. 2017, 10, 413–421. [Google Scholar] [CrossRef] [PubMed]
- Brin, M.F.; Boodhoo, T.I.; Pogoda, J.M.; James, L.M.; Demos, G.; Terashima, Y.; Gu, J.; Eadie, N.; Bowen, B.L. Safety and tolerability of onabotulinumtoxinA in the treatment of facial lines: A meta-analysis of individual patient data from global clinical registration studies in 1678 participants. J. Am. Acad. Dermatol. 2009, 61, 961–970.e1. [Google Scholar] [CrossRef] [PubMed]
- Davidovic, K.; Melnikov, D.V.; Frank, K.; Gavril, D.; Green, J.B.; Freytag, D.L.; Heisinger, S.; Pavicic, T.; Gold, M.H.; Cotofana, S. To click or not to click—The importance of understanding the layers of the forehead when injecting neuromodulators—A clinical, prospective, interventional, split-face study. J. Cosmet. Dermatol. 2021, 20, 1385–1392. [Google Scholar] [CrossRef] [PubMed]
- Sandre, M. New anatomical insights into preventing brow ptosis with botulinum toxin-A use. Can. Dermatol. Today 2021, 2, 30–34. [Google Scholar]
- Ryu, J.H.; Shim, J.H.; Yeom, J.H.; Shin, W.J.; Cho, S.Y.; Jeon, W.J. Ultrasound-guided greater occipital nerve block with botulinum toxin for patients with chronic headache in the occipital area: A randomized controlled trial. Korean J. Anesthesiol. 2019, 72, 479–485. [Google Scholar] [CrossRef]
- Omoigui, S.; Irene, S. Treatment of ptosis as a complication of botulinum toxin injection. Pain Med. 2005, 6, 149–151. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Song, J.; Choi, S.S.; Choi, S.J.; Lee, C.H. Efficacy of Botulinum Type A Injection for the Treatment of Postherpetic Neuralgia and Pruritus Persisting for More Than Four Years—A Case Report. Medicina 2024, 60, 1317. https://doi.org/10.3390/medicina60081317
Song J, Choi SS, Choi SJ, Lee CH. Efficacy of Botulinum Type A Injection for the Treatment of Postherpetic Neuralgia and Pruritus Persisting for More Than Four Years—A Case Report. Medicina. 2024; 60(8):1317. https://doi.org/10.3390/medicina60081317
Chicago/Turabian StyleSong, Jihyun, Sang Sik Choi, Seok Jun Choi, and Chung Hun Lee. 2024. "Efficacy of Botulinum Type A Injection for the Treatment of Postherpetic Neuralgia and Pruritus Persisting for More Than Four Years—A Case Report" Medicina 60, no. 8: 1317. https://doi.org/10.3390/medicina60081317
APA StyleSong, J., Choi, S. S., Choi, S. J., & Lee, C. H. (2024). Efficacy of Botulinum Type A Injection for the Treatment of Postherpetic Neuralgia and Pruritus Persisting for More Than Four Years—A Case Report. Medicina, 60(8), 1317. https://doi.org/10.3390/medicina60081317